No Data
No Data
Jaguar Health to Present Data on Crofelemer for CTD in Breast Cancer Patients
Poster Presentation Describing the Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients to Take Place December 11, 2024 at San Antonio Breast Cancer Symposium (SABCS)
U.S. Investigator-Initiated Trial To Evaluate Efficacy And Safety Of Jaguar Health's Crofelemer For Short Bowel Syndrome With Intestinal Failure Begins
U.S. Investigator-Initiated Trial (IIT) to Evaluate Jaguar Health's Crofelemer for Short Bowel Syndrome With Intestinal Failure (SBS-IF) Begins
Jaguar Health Announces Publication of Article on Canalevia-CA1
Jaguar Health Presenting December 3rd at NobleCon20 and December 5th at the Emerging Growth Conference
Unlock the Full List